67 related articles for article (PubMed ID: 32440836)
1. Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management.
Arai K; Nishikawa T; Yuasa S; Shirabe SI; Matsuzawa Y; Ohtsu S; Hirao K; Mori H
Diabetes Ther; 2020 Jul; 11(7):1497-1511. PubMed ID: 32440836
[TBL] [Abstract][Full Text] [Related]
2. The status of glycemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15,652 patients with diabetes mellitus.
Arai K; Hirao K; Matsuba I; Takai M; Matoba K; Takeda H; Kanamori A; Yamauchi M; Mori H; Terauchi Y
Diabetes Res Clin Pract; 2009 Mar; 83(3):397-401. PubMed ID: 19124170
[TBL] [Abstract][Full Text] [Related]
3. Cross sectional study on proportion of sulfonylureas among various oral antidiabetic drugs using for Japanese patients with type 2 diabetes, analyzed from NSAID Study-2.
Arai K; Nishikawa T; Shirabe SI; Matsuzawa Y; Ohtsu S; Yuasa S; Hirao K; Mori H
Diabetol Int; 2022 Jan; 13(1):169-176. PubMed ID: 35059253
[TBL] [Abstract][Full Text] [Related]
4. Differences in Dental Care Referral for Diabetic Patients Between General Practitioners and Diabetes Specialists in Japan, Analyzed from NSAID-Study 3.
Arai K; Nishikawa T; Matsuzawa Y; Ohtsu S; Shirabe SI; Yuasa S; Hirao K; Mori H
Diabetes Ther; 2022 Feb; 13(2):379-385. PubMed ID: 34958439
[TBL] [Abstract][Full Text] [Related]
5. Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross-sectional survey of 15,652 patients.
Arai K; Takai M; Hirao K; Matsuba I; Matoba K; Takeda H; Kanamori A; Yamauchi M; Mori H; Terauchi Y
J Diabetes Investig; 2012 Aug; 3(4):396-401. PubMed ID: 24843596
[TBL] [Abstract][Full Text] [Related]
6. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
Sonmez A; Tasci I; Demirci I; Haymana C; Barcin C; Aydin H; Cetinkalp S; Ozturk FY; Gul K; Sabuncu T; Satman I; Bayram F;
Diabetes Ther; 2020 May; 11(5):1045-1059. PubMed ID: 32088879
[TBL] [Abstract][Full Text] [Related]
7. Patients' empowerment, physicians' perceptions, and achievement of therapeutic goals in patients with type 1 and type 2 diabetes mellitus in Mexico.
Lavalle-González FJ; Chiquete E
Patient Prefer Adherence; 2016; 10():1349-57. PubMed ID: 27555751
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis.
Suzuki S; Desai U; Strizek A; Ivanova J; Garcia-Horton V; Cai Z; Schmerold L; Liu X; Perez-Nieves M
Diabetes Ther; 2018 Jun; 9(3):1125-1141. PubMed ID: 29663262
[TBL] [Abstract][Full Text] [Related]
9. Screening for celiac disease in poorly controlled type 2 diabetes mellitus: worth it or not?
Kizilgul M; Ozcelik O; Beysel S; Akinci H; Kan S; Ucan B; Apaydin M; Cakal E
BMC Endocr Disord; 2017 Oct; 17(1):62. PubMed ID: 28985731
[TBL] [Abstract][Full Text] [Related]
10. Analysis of weight at birth and at diagnosis of childhood-onset type 2 diabetes mellitus in Japan.
Sugihara S; Sasaki N; Amemiya S; Kohno H; Tanaka T; Matsuura N
Pediatr Diabetes; 2008 Jul; 9(4 Pt 1):285-90. PubMed ID: 18466207
[TBL] [Abstract][Full Text] [Related]
11. A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes.
Baxter M; Morimoto Y; Tamiwa M; Hattori M; Peng XV; Lubwama R; Maegawa H
Diabetes Ther; 2020 Jul; 11(7):1481-1496. PubMed ID: 32445125
[TBL] [Abstract][Full Text] [Related]
12. Factors Influencing the Prescribing Preferences of Physicians for Drug-Naive Patients with Type 2 Diabetes Mellitus in the Real-World Setting in Japan: Insight from a Web Survey.
Murayama H; Imai K; Odawara M
Diabetes Ther; 2018 Jun; 9(3):1185-1199. PubMed ID: 29696567
[TBL] [Abstract][Full Text] [Related]
13. Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus.
Katsuno T; Ikeda H; Namba M
Diabetes Ther; 2016 Jun; 7(2):309-20. PubMed ID: 27114254
[TBL] [Abstract][Full Text] [Related]
14. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
Yin TT; Bi Y; Li P; Shen SM; Xiong XL; Gao LJ; Jiang C; Wang Y; Feng WH; Zhu DL
Diabetes Ther; 2018 Jun; 9(3):1253-1267. PubMed ID: 29744819
[TBL] [Abstract][Full Text] [Related]
16. Patient and General Practitioner characteristics influencing the management of non-insulin-treated diabetes mellitus: A cross-sectional study in Italy.
Ferroni E; Casotto V; Pigato M; Scroccaro G; Corti MC; Fedeli U; Saugo M
Diabetes Res Clin Pract; 2016 Jun; 116():192-201. PubMed ID: 27321335
[TBL] [Abstract][Full Text] [Related]
17. Trends in medical performance in diabetic patients in primary care clinics compared with those in hospitals: Shiga Diabetes Clinical Survey, Japan, 2000-2012.
Miyazawa I; Kadota A; Okamoto M; Miura K; Maegawa H; Ohnishi A;
Diabetol Int; 2017 Mar; 8(1):59-68. PubMed ID: 30603308
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China.
Liu G; Dou J; Pan Y; Yan Y; Zhu H; Lu J; Gaisano H; Ji L; He Y
Front Endocrinol (Lausanne); 2018; 9():639. PubMed ID: 30420835
[No Abstract] [Full Text] [Related]
19. Insulin therapy may increase blood pressure levels in type 2 diabetes mellitus.
Kanoun F; Ben Amor Z; Zouari B; Ben Khalifa F
Diabetes Metab; 2001 Dec; 27(6):695-700. PubMed ID: 11852379
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
